Annual probability of incident cancer in a <1cm BD-IMPN |
0.1% |
1% |
2.0% |
3% |
If the annual rate of malignant transformation of a benign IPMN exceeds threshold then surgery is superior to surveillance |
Baseline probability of prevalent cancer in a <1cm BD-IPMN |
1% |
4.5% |
6.0% |
7.5% |
Once the prevalent rate of cancer exceeds threshold surgery is superior to surveillance |
Annual death rate from untreated malignant IPMN |
60% |
65% |
69% |
73% |
If the annual mortality rate for an untreated malignant IPMN exceeds threshold then surgery is superior to surveillance |
Perioperative mortality with pancreaticoduodenectomy |
6.4% |
6% |
3.8% |
2.0% |
When the mortality rate of a Pancreaticoduodenectomy is below threshold then a Pancreaticoduodenectomy is the superior strategy. |
Peri-procedural mortality with EUS-FNA |
0.01% |
0.01% |
0.01% |
0.01% |
If the mortality rate with EUS-FNA increases above threshold then noninvasive surveillance becomes the superior strategy over invasive surveillance. |